NEOGENOMICS INC — Director's Dealing 2021

Dec 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-30

Reporting Person: Brown Douglas Matthew (Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-30	Common Stock	A	30572	—	Acquired	42216	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (45017.0)	45017	Direct
Stock Option (Right to Buy)	$53.17	2028-03-02	Common Stock (26378.0)	26378	Direct

Footnotes

F1: On December 30, 2021, Mr. Brown was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.

F2: On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F3: On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.